AI Verdict
INVZW has stronger fundamentals based on our AI analysis.
IOBT vs INVZW Fundamental Comparison
| Metric | IOBT | INVZW |
|---|---|---|
| Revenue | N/A | N/A |
| Net Income | $-57.0M | N/A |
| Net Margin | N/A | N/A |
| ROE | -6,258.6% | N/A |
| ROA | -142.7% | N/A |
| Current Ratio | 2.01x | N/A |
| Debt/Equity | 18.29x | N/A |
| EPS | $-0.86 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IOBT vs INVZW: Frequently Asked Questions
Is IOBT or INVZW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), INVZW has stronger fundamentals. IOBT is rated STRONG SELL (95% confidence) while INVZW is rated SELL (95% confidence). This is not investment advice.
How does IOBT compare to INVZW fundamentally?
IO Biotech, Inc. has ROE of -6,258.6% vs Innoviz Technologies Ltd.'s N/A. Net margins are N/A vs N/A respectively.
Which stock pays higher dividends, IOBT or INVZW?
IOBT has a dividend yield of N/A or no dividend while INVZW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IOBT or INVZW for long term?
For long-term investing, consider that IOBT has STRONG SELL rating with 95% confidence, while INVZW has SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IOBT vs INVZW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IOBT vs INVZW, the AI consensus favors INVZW based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.